FDA Inspection 1007625 — Newark Beth Israel Med Ctr IRB
The FDA completed an inspection of Newark Beth Israel Med Ctr IRB on Mar 23, 2017 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 23, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional Details
IRB